Guardant Health, Inc. (GH) vs Revvity Inc. (RVTY)

Guardant Health, Inc. and Revvity Inc. are both Diagnostics & Research companies. Guardant Health, Inc. is the larger, with a market value of $20.6B against $16.8B — 1.2× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Revvity Inc. trades at 71.9×. Guardant Health, Inc. grew revenue faster over the last twelve months: 41.7% against 4.56%. Revvity Inc. has the higher net margin (8.61% vs −37.9%) and the higher return on invested capital (2.50% vs −25.7%). Across the 18 metrics below, Guardant Health, Inc. leads on 9 and Revvity Inc. on 9.

Valuation

Metric GH RVTY Diagnostics & Research median
P/E n/m 71.89 34.52
P/S 16.20 5.73 4.24
P/B n/m 2.33 3.42
Price to free cash flow n/m 28.19 33.51
EV/EBITDA n/m 25.08 23.44
EV/Sales 16.55 6.61 5.18
Earnings yield (2.39%) 1.39% (1.50%)
Free cash flow yield (1.21%) 3.55% 0.00%

Profitability

Metric GH RVTY Diagnostics & Research median
Gross margin 65.19% 55.91% 48.32%
Operating margin (39.41%) 12.65% (5.68%)
Net margin (37.93%) 8.61% (4.10%)
Free cash flow margin (18.15%) 20.48% 0.00%
Return on equity 153.90% 0.00% 0.00%
Return on assets (30.68%) 2.14% (6.05%)
Return on invested capital (25.68%) 2.50% 0.00%

Growth

Metric GH RVTY Diagnostics & Research median
Revenue growth (TTM) 41.69% 4.56% 8.99%
EPS growth (last fiscal year) 6.74% (5.91%) 20.36%
Revenue growth, 5-year CAGR 27.92% 1.41% 7.30%
Net income growth, 5-year CAGR 0.00% (19.82%) 0.00%

Health

Metric GH RVTY Diagnostics & Research median
Debt to equity (5.45) 0.36 0.01
Current ratio 3.60 2.65 2.27
Net debt to EBITDA (0.75) 3.00 0.68

Dividend

Metric GH RVTY Diagnostics & Research median
Dividend yield — 0.19% 0.67%
Payout ratio — 0.12 0.20

Size

Metric GH RVTY Diagnostics & Research median
Market cap 20.59b 16.83b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack